Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy
- 1 May 1998
- journal article
- Published by Elsevier in Kidney International
- Vol. 53 (5) , 1162-1171
- https://doi.org/10.1046/j.1523-1755.1998.00846.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Amino-terminal Processing of Cell Surface Heparin-binding Epidermal Growth Factor-like Growth Factor Up-regulates Its Juxtacrine but Not Its Paracrine Growth Factor ActivityJournal of Biological Chemistry, 1996
- Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosisKidney International, 1995
- Passive dual immunization against tumour necrosis factor-alpha (TNF-α) and IL-1β maximally ameliorates acute aminonucleoside nephrosisClinical and Experimental Immunology, 1995
- Induction of heparin-binding epidermal growth factor-like growth factor mRNA by protein kinase C activatorsKidney International, 1994
- Regulation of Heparin Binding-Epidermal Growth Factor-like Growth Factor Gene Expression by LDL and Oxidized LDL in Rat Mesangial CellsBiochemical and Biophysical Research Communications, 1994
- Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix.The Journal of cell biology, 1993
- Betacellulin: a mitogen from pancreatic beta cell tumorsScience, 1993
- Messenger RNA Expression for Growth Factors in Glomeruli from Focal Glomerular SclerosisClinical Immunology and Immunopathology, 1993
- Heparin-Binding EGF-like Growth Factor: Characterization of Rat and Mouse cDNA Clones, Protein Domain Conservation across Species, and Transcript Expression in TissuesBiochemical and Biophysical Research Communications, 1993
- Altered glomerular extracellular matrix synthesis in experimental membranous nephropathyKidney International, 1992